MedTrace Logo

Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery

NCT03607227 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-04-08

No results posted yet for this study

Summary

The aim of the study is to assess the effects of a continuous popliteal block on postoperative pain and recovery after major ear, nose and throat surgery with microvascular free flap reconstruction using a fibula graft.

Conditions

Interventions

DRUG

Levobupivacaine

Active substance. Levobupivacaine 3.75 mg/ml 15 ml is given as a bolus injection at start of surgery, followed by ropivacaine 2 mg/ml continous infusion 5-8 ml/h from the end of surgery until end of intervention at the fourth to seventh postoperative day.

DRUG

Saline Solution

Placebo. Saline solution (NaCl 0.9%) is given in equivalent intervals and doses as the active substances.

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Louise Walther Sturesson, MD, PhD · Skåne University hospital, Region Skåne

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-04-06
Completion
2021-04-07

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03607227 on ClinicalTrials.gov